Liver Cancer Trial, Recruiting NCT07147335 Sponsor: The First Affiliated Hospital of University of South China Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT07147335
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with liver cirrhosis and chronic hepatitis (long-term liver inflammation)
  • People aged between 18 and 75 years, of any gender
  • People who are willing to take part in the study and have signed a consent form agreeing to participate
  • People who have not taken part in any other clinical trial in the past 3 months

Who may not be able to join:

  • People who are currently pregnant or breastfeeding
  • People whose medical records, blood test results, or scan/imaging records are incomplete
  • People whose follow-up with the medical team ended before the study's observation points were reached
  • People younger than 18 or older than 75 years of age
  • People who have a serious ongoing illness affecting the heart, brain, lungs, kidneys, or blood-producing systems
  • People who are currently participating in, or have participated in, another clinical trial within the past 3 months
  • People who have been diagnosed with liver cancer (a specific type called hepatocellular carcinoma)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 17773486769

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The First Affiliated Hospital of University of South China
Registry
ClinicalTrials.gov
Start date
16 May 2025
Est. completion
31 March 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

HCC

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov